ДИАГНОСТИЧЕСКОЕ И ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ АНТИТЕЛ К КАРБАМИЛИРОВАННОМУ БЕЛКУ (ANTI-CARP) У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ В ТАШКЕНТЕ

Мирахмедова Х.Т.; Рахимова М.Р.

Authors

Мирахмедова Х.Т. Author
Рахимова М.Р. Author

Abstract

Обнаружение специфического профиля аутоантител в сыворотке крови больных ревматоидным артритом (РА) играет важную роль в диагностике и стратегии лечения. Недавно был обнаружен новый тип аутоантител против карбамилированных белков – anti-CarP, которые могут иметь важную диагностическую ценность при РА.

References

1. Derksen VF, Ajeganova S, Trouw LA, van der Helm-van Mil AH, Hafstrom I, Huizinga TW, Toes RE, Svensson B, van der Woude D (2017) Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present. Ann Rheum Dis 76(4):716–720. https://doi. org/10.1136/annrheumdis-2016-209794.

2. Lagrutta M, Alle G, Parodi RL, Greca AA (2016) Severe extraarticular manifestations of rheumatoid arthritis in absence of concomitant joint involvement following long-term spontaneous remission. A case report. Reumatol Clin 12(4):223–225. https://doi. org/10.1016/j.reuma.2015.07.006.

3. Krougly LB, Fomicheva OA, Karpov YA, Popkova TV, Novikova DS, Nasonov EL (2016) Cardiovascular complications of rheumatoid arthritis: prevalence and pathogenesis. Kardiologiia 56(6):89– 95.

4. Onuora S (2012) Rheumatoid arthritis: RF levels predict RA risk in the general population. Nat Rev Rheumatol 8(10):562. https://doi. org/10.1038/nrrheum.2012.159.

5. Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM (2017) Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol 31(1):3–18. https://doi.org/10.1016/j.berh.2017.08.003.

6. Hensvold AH, Frisell T, Magnusson PK, Holmdahl R, Askling J, Catrina AI (2017) How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 populationrepresentative Swedish twins. Ann Rheum Dis 76(1):119–125. https://doi.org/10.1136/annrheumdis-2015-208980.

7. Gafvels C, Hagerstrom M, Rane K, Wajngot A, Wandell PE (2016) Depression and anxiety after 2 years of follow-up in patients diagnosed with diabetes or rheumatoid arthritis. Health Psychol Open 3(2):2055102916678107. https://doi.org/10.1177/ 2055102916678107.

8. Goes ACJ, Reis LAB, Silva MBG, Kahlow BS, Skare TL (2017) Rheumatoid arthritis and sleep quality. Rev Bras Reumatol 57(4): 294–298. https://doi.org/10.1016/j.rbre.2016.07.011

9. Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389(10086):2338–2348. https://doi.org/10. 1016/S0140-6736(17)31491-5.

10. Oliveira RA, Fierro IM (2018) New strategies for patenting biological medicines used in rheumatoid arthritis treatment. Expert Opin Ther Pat 28(8):635–646. https://doi.org/10.1080/13543776.2018. 1502748.

11. Szodoray P, Szabo Z, Kapitany A, Gyetvai A, Lakos G, Szanto S, Szucs G, Szekanecz Z (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9(3):140–143. https://doi.org/10.1016/j.autrev. 2009.04.006.

12. Vos I, Van Mol C, Trouw LA, Mahler M, Bakker JA, Van Offel J, De Clerck L, Huizinga TW (2017) Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays. Clin Rheumatol 36(7):1487–1492. https://doi.org/10.1007/ s10067-017-3684-8.

13. Hoffman IE, Peene I, Cebecauer L, Isenberg D, Huizinga TW, Union A, Meheus L, De Bosschere K, Hulstaert F, Veys EM, De Keyser F (2005) Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis 64(2):330–332. https://doi.org/10.1136/ard.2004.022111.

14. Vencovsky J (1991) Rheumatoid factor in rheumatoid arthritis in old age. Cas Lek Cesk 130(4):108–111.

15. Mirrakhimova M. Kh, Nishanbaeva N. Yu, Kasimova M. B PSYCHOSOMATIC RELATIONSHIPS IN ATOPIC DERMATITIS.// International Journal of Education, Social Science & Humanities. FARS Publishers,Impact factor (SJIF) = 6.786//Volume-11| Issue3| 2023,pp. 734-738

16. Mirrakhimova M. Kh, Nishanbaeva N. Yu, Shamsiyeva E.R, Saydaliev A.B//Atopic Dermatitis and Mental Disorders Psychosomatic Relationships//Journal of Coastal Life Medicine. JCLMM 1/11 (2023) //pp.1153–1159

17. Bharadwaj A, Aggarwal A, Misra R (1999) Clinical relevance of IgA rheumatoid factor (RF) in children with juvenile rheumatoid arthritis. Rheumatol Int 19(1–2):47–49.

18. Chatpar PC, Muller D, Gruber B, Kaplan AP, Gorevic PD (1986) Prevalence of IgE rheumatoid factor (IgE RF) in mixed cryoglobulinemia and rheumatoid arthritis. Clin Exp Rheumatol 4(4):313–317.

19. Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 46(1):65–71.

20. Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Keystone E, Thorne C, Bombardier C (2018) ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). RMD Open 4(2):e000738. https://doi.org/10. 1136/rmdopen-2018-000738.

21. Porto LS, Tavares WCJ, Costa DA, Lanna CC, Kakehasi AM (2017) Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study. Rev Bras Reumatol 57(1):15–22. https://doi.org/10.1016/j. rbre.2015.07.018.

22. Burgers LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, van der Helm-van Mil AH (2017) Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis. Ann Rheum Dis 76(10):1751–1754. https://doi.org/10.1136/ annrheumdis-2017-211325

23. Hensvold AH, Catrina AI (2018) Challenging judgement of a lowpositive ACPA test in the context of individuals at risk of RA. Ann Rheum Dis 77(6):e30. https://doi.org/10.1136/annrheumdis-2016- 211062.

24. Kalim S, Karumanchi SA, Thadhani RI, Berg AH (2014) Protein carbamylation in kidney disease: pathogenesis and clinical implications. Am J Kidney Dis 64(5):793–803. https://doi.org/10.1053/j. ajkd.2014.04.034.

25. Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 108(42):17372–17377. https://doi.org/10.1073/pnas. 1114465108.

26. Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Hamann D, van Schaardenburg D, Toes RE, Trouw LA (2014) Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 73(4):780–783. https://doi.org/10.1136/ annrheumdis-2013-204154.

27. Yee A, Webb T, Seaman A, Infantino M, Meacci F, Manfredi M, Benucci M, Lakos G, Favalli E, Schioppo T, Meroni PL, Mahler M (2015) Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res 61(1–2):24–30. https://doi.org/10.1007/s12026-014- 8560.

28. Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Kallberg H, Malmstrom V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D (2014) Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their Clin Rheumatol relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis 73(10):1761–1768. https://doi. org/10.1136/annrheumdis-2013-205109.

29. Larsen A (1995) How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 22(10):1974–1975.

30. Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafstrom I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH (2017) The association between anticarbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ann Rheum Dis 76(1):112–118. https://doi.org/10.1136/annrheumdis-2015- 208870.

31. Kumar S, Pangtey G, Gupta R, Rehan HS, Gupta LK (2017) Assessment of anti-CarP antibodies, disease activity and quality of life in rheumatoid arthritis patients on conventional and biological disease-modifying antirheumatic drugs. Reumatologia 55(1): 4–9. https://doi.org/10.5114/reum.2017.66680.

32. de Moel EC, Derksen V, Trouw LA, Bang H, Collee G, Lard LR, Ramiro S, Huizinga TWJ, Allaart CF, Toes REM, van der Woude D (2019) In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Res Ther 21(1):28. https://doi.org/10.1186/ s13075-019-1815.